Influenza vaccines: Where do we stand? Where do we go?: A bumpy but steady road upwards.
Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands. Electronic address: g.rimmelzwaan@erasmusmc.nl.
Guus
G
Rimmelzwaan
Ghent University, Ghent, Belgium.
Isabel
I
Leroux-Roels
Jenner Institute, University of Oxford, Oxford, UK.
Sarah
S
Gilbert
Sanofi Pasteur, Lyon, France.
Angus
A
Thomson
D000940:Antigenic Variation; D000956:Antigens, Viral / Q000235:genetics; D003226:Congresses as Topic; D006801:Humans; D017589:Immunization Programs; D009980:Influenza A virus / Q000145:classification; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control*; D058873:Pandemics / Q000517:prevention & control; D014611:Vaccination
D000956:Antigens, Viral; D007252:Influenza Vaccines